Efficacy of Enobosarm, a Selective Androgen Receptor (AR) Targeting Agent, Correlates with the Degree of AR Positivity in Advanced AR+/estrogen Receptor (ER)+ Breast Cancer in an International Phase 2 Clinical Study.
JOURNAL OF CLINICAL ONCOLOGY（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined